NASDAQ: STRO
Sutro Biopharma Inc Stock Ownership - Who owns Sutro Biopharma?

Insider buying vs selling

Have Sutro Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David PaulingChief Admin. Ofcr. GC2025-10-1512,504$0.80
$9.99kBuy
Jane ChungChief Executive Officer2025-10-1512,500$0.80
$10.01kBuy
Hanspeter GerberCHIEF SCIENTIFIC OFFICER2025-10-1517,000$0.80
$13.60kBuy
Gregory K. ChowCFO2025-10-1519,750$0.81
$16.00kBuy
Connie MatsuiDirector2025-10-1550,000$0.80
$39.95kBuy
Hanspeter GerberCHIEF SCIENTIFIC OFFICER2025-09-1813,417$0.90
$12.08kSell
Jane ChungChief Executive Officer2025-08-096,708$0.80
$5.37kSell
Barbara LeymanChief Business Officer2025-07-088,944$0.78
$6.98kSell
Edward C. AlbiniCFO AND SECRETARY2025-05-1515,995$0.88
$14.08kSell
Linda A. FitzpatrickCHIEF PEOPLE COMM. OFFICER2025-05-0113,538$1.07
$14.49kSell

1 of 3

STRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STRO insiders and whales buy or sell their stock.

STRO Shareholders

What type of owners hold Sutro Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC7.68%6,488,324$7.53MInstitution
Kynam Capital Management LP6.02%5,088,099$5.90MInstitution
Millennium Management LLC5.60%4,732,243$5.49MInstitution
Vanguard Group Inc4.87%4,115,250$4.77MInstitution
Velan Capital Investment Management LP3.62%3,060,000$3.55MInstitution
Acadian Asset Management LLC3.60%3,042,238$3.53MInstitution
Merck Co Inc3.22%2,723,509$3.16MInsider
Merck Co Inc3.22%2,723,509$3.16MInstitution
Vestal Point Capital LP3.08%2,600,000$3.02MInstitution
Tang Capital Management LLC3.03%2,561,586$2.97MInstitution

1 of 3

STRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STRO65.81%18.36%Net SellingNet Buying
CNTB4.39%0.00%
STTK59.88%31.06%Net BuyingNet Buying
ADVM30.21%69.79%Net Buying
KLRS4.47%95.53%Net Selling

Sutro Biopharma Stock Ownership FAQ

Who owns Sutro Biopharma?

Sutro Biopharma (NASDAQ: STRO) is owned by 65.81% institutional shareholders, 18.36% Sutro Biopharma insiders, and 15.83% retail investors. Merck Co Inc is the largest individual Sutro Biopharma shareholder, owning 2.72M shares representing 3.22% of the company. Merck Co Inc's Sutro Biopharma shares are currently valued at $2.89M.

If you're new to stock investing, here's how to buy Sutro Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.